Nuvaira Announces Four Clinical Abstracts Accepted for Presentation at ERS International Congress
07. September 2017 08:00 ET
|
Nuvaira, Inc.
MILAN, Italy, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Nuvaira, a developer of medical devices to treat obstructive lung diseases, today announced that four scientific abstracts featuring the Nuvaira™...
Nuvaira Announces Enrollment Completion in First Sham-Controlled Clinical Trial of Targeted Lung Denervation for COPD
27. Juni 2017 09:00 ET
|
Nuvaira, Inc.
MINNEAPOLIS, June 27, 2017 (GLOBE NEWSWIRE) -- Nuvaira (formerly known as Holaira), a developer of medical devices to treat obstructive lung diseases, today announced completion of patient...